Tissue engineering has made significant progress in the last few decades, with the potential to regenerate damaged or diseased tissues. However, a major hurdle in this field is the lack of vascularization in engineered tissues, hindering their viability beyond a certain size due to inadequate oxygen and nutrient diffusion. To address this challenge, in vitro vascularization has become a critical focus, with bioprinting emerging as a promising method for fabricating vascular templates. This review delves into the current strategies, cell sources, materials, and outcomes in the fields of vascularization and bioprinting.
Vascular networks play a crucial role in transporting blood, nutrients, and waste throughout the body. The intricate structure of blood vessels, consisting of layers like intima, media, and adventitia, varies depending on their location and function. Vasculogenesis and angiogenesis are the key processes in vascular formation, involving the de novo development of blood vessels during embryogenesis and the formation of new vessels from existing ones, respectively. Growth factors like VEGF, bFGF, and PDGF play essential roles in angiogenesis and vessel remodeling. Bioprinting, utilizing hydrogels or bioinks made from natural (e.g., collagen, fibrin) or synthetic (e.g., PEG) materials, offers a precise method for creating vascularized tissues, enabling the patterning of cells and materials in a 3D environment.
Studies have demonstrated the successful bioprinting of vascular constructs using various materials. Natural bioinks like agarose, alginate, collagen, fibrin, gelatin, and hyaluronic acid have been widely used for their biocompatibility and similarity to the ECM. Agarose, for instance, allows for the formation of vascular channels and supports cell migration and capillary formation. Alginate, with its ionic crosslinking properties, has been utilized to create complex vascular structures. Collagen, being a major component of the ECM, promotes cell adhesion and growth but requires optimization for bioprinting due to slow gelation. Fibrin, known for its involvement in blood clotting, has shown promise in creating vascular networks in vitro.
Furthermore, synthetic bioinks like Pluronic and PEG offer advantages in reproducibility and tunable mechanical properties. Pluronic has been used as a sacrificial material to create perfusable channels, supporting the development of vascular networks. PEG, a biologically inert polymer, can be modified to enhance its mechanical properties and aid in polymerization processes. Blending natural and synthetic bioinks has also shown success in improving the overall performance of bioprinted vascular constructs. By combining the strengths of different materials and cells, bioprinting has the potential to revolutionize tissue engineering by enabling the creation of functional vascularized tissues for various applications.
Key Takeaways:
1. Bioprinting presents a promising avenue for creating vascularized tissues by utilizing natural and synthetic bioinks.
2. Materials like collagen, alginate, Pluronic, and PEG offer unique properties for constructing intricate vascular networks.
3. Vascularization processes, including vasculogenesis and angiogenesis, play crucial roles in tissue engineering and can be mimicked through bioprinting techniques.
4. The successful bioprinting of vascular structures requires a deep understanding of material properties, cell behavior, and the mechanisms involved in vascular formation.
Read more on ncbi.nlm.nih.gov